Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.59 USD | +2.57% | +9.68% | -28.75% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- SYRS Stock
- Revisions Syros Pharmaceuticals, Inc.